Free discreet shipping on every order | Save 10% on $150+ — code WELLNESS10 | Save 15% on $300+ — code WELLNESS15 | Save 20% on $600+ — code WELLNESS20 | Your partner discount is applied at checkout | Free Shipping on $150+ after discounts

Tirzepatide, Cagrilintide, NAD+ and SS-31 Research Set — Research Use Only

Original price was: $398.00.Current price is: $318.40. You save $79.60

Four compounds studied against four distinct mechanisms — Tirzepatide, Cagrilintide, NAD+ and SS-31: incretin signalling, amylin satiety, mitochondrial co-enzyme supply and cardiolipin structure. Supplied together at a lower combined cost than the individual vials, for laboratory research and identification purposes only.

Original price was: $116.47.Current price is: $99.00. — or subscribe to save 10%
Original price was: $111.76.Current price is: $95.00. — or subscribe to save 10%

Availability: In stock

Original price was: $76.47.Current price is: $65.00.
Original price was: $163.53.Current price is: $139.00.

Availability: In stock

⬡ Earn 955 Research Points with this purchase

Research Disclaimer: All products currently listed on this site are for research purposes only.

Ships in 1-2 Business Days Discreet, temperature-controlled packaging
Research Support Included Chat & email — our team knows the research
Research Grade ≥98% purity standard
Fast Fulfillment Ships in 1–2 days

METABOLIC RESEARCH COMPOUNDS

Four compounds, four distinct mechanisms.

Tirzepatide, Cagrilintide, NAD+ and SS-31 — incretin signalling, amylin satiety, mitochondrial co-enzyme supply, and cardiolipin structure. Four separate research questions, available individually or in one order.

✓ Save 20% — $79.60 off when you buy these together

📦 Ships in 1–2 Business Days
📚 Published research linked per compound

What each compound is studied for.

Incretin receptor pharmacology, amylin signalling, mitochondrial co-enzyme availability and inner-membrane structure are four separate literatures, and they are not equally well supported. Tirzepatide has the most mature clinical record of the four. Cagrilintide has published phase 2 work behind it. NAD+ rests largely on established biochemistry, with human precursor studies that are mostly small and short. SS-31 has been studied mainly in rare mitochondrial disease populations, which does not generalise to healthy physiology. Grouping the four is a purchasing convenience. Nothing here establishes that they should be used together, and we do not publish guidance on combining compounds.

What’s in this stack.

COMPOUND 01
Tirzepatide — 60mg/vial

Dual GIP and GLP-1 receptor agonist — one peptide that binds both incretin receptors. Published clinical trials report effects on glycaemic and body-composition endpoints. Those trials used pharmaceutical-grade material under medical supervision, and are cited here as background on the molecule rather than as a description of this product.

COMPOUND 02
Cagrilintide — 10mg/vial

Long-acting amylin analogue. Amylin is co-secreted with insulin at meals and signals satiety through area postrema pathways. Cagrilintide has published phase 2 work behind it; PTW makes no claim about its use alongside any other compound or medicine.

COMPOUND 03
NAD+ — 500mg/vial

Cellular energy co-enzyme. Required for mitochondrial electron transport chain function and ATP production, and the substrate the sirtuin enzymes depend on. Levels decline with age.

COMPOUND 04
SS-31 (Elamipretide) — 50mg/vial

Mitochondria-targeted tetrapeptide. Concentrates in the inner mitochondrial membrane and binds cardiolipin, the phospholipid that scaffolds the respiratory chain. Studied for whether preserving that structure preserves electron transport efficiency under oxidative stress.

What the published work describes.

1

Tirzepatide — Dual Incretin Pathway Activation

A synthetic peptide that co-activates GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. The two receptors are distributed differently through the body: GIP receptor activity has been studied at adipose tissue and insulin sensitivity, GLP-1 receptor activity at appetite signalling, gastric emptying and hepatic glucose output. Whether engaging both produces something the mono-agonists do not is the open question the literature is still working through.

2

Cagrilintide — Amylin-Pathway Satiety Extension

A long-acting amylin receptor agonist. Amylin is co-secreted with insulin at meals and signals satiety through area postrema and nucleus tractus solitarius pathways, independent of GLP-1. Its extended half-life is what the published phase 2 work examines. PTW makes no claim about its use alongside any other compound or medicine.

3

NAD+ — Role in Oxidative Phosphorylation

Nicotinamide adenine dinucleotide is the primary co-enzyme in mitochondrial oxidative phosphorylation. NAD+ levels decline with age, and are consumed faster under oxidative stress. Depletion is associated in the literature with reduced fat oxidation efficiency, lower ATP output and limited sirtuin activity. Whether supplementation changes any of that in a person is a separate question from the biochemistry, and a far less settled one.

Research Note: Portal to Wellness does not publish administration guidance. We do not provide dosing, routes, schedules, cycling or combination advice, and we cannot answer questions about use in humans or animals. Published trial and preclinical literature is where pharmacokinetic and administration data belongs; the compound pages below link the primary sources.

Save 20% when you buy these together.

Metabolic Optimization Kit — all four compounds
Tirzepatide — 60mg/vial
$79.20
Cagrilintide — 10mg/vial
$76.00
NAD+ — 500mg/vial
$52.00
SS-31 (Elamipretide) — 50mg/vial
$111.20
Bundle Total
$318.40
You save $79.60 vs. buying them separately ($398.00)

Metabolic Optimization Kit — all four compounds →

Bundle pricing applied automatically at checkout. Each compound is also available individually.

All products on Portal to Wellness are sold for research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm that you are a qualified researcher.

(function () {
document.querySelectorAll(‘a[data-ptw-bp-scroll]’).forEach(function (btn) {
btn.addEventListener(‘click’, function (e) {
var form = document.querySelector(‘form.cart, .woosb-wrap’);
if (!form) { return; }
e.preventDefault();
form.scrollIntoView({ behavior: ‘smooth’, block: ‘center’ });
});
});
})();

Not sure which compounds fit your research? Browse the Research Hub →

Customer Reviews

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide, Cagrilintide, NAD+ and SS-31 Research Set — Research Use Only”

Your email address will not be published. Required fields are marked *

All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion. Refund Policy
Scroll to Top
All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, human consumption, or veterinary use. Not for human use. Must be 18 years or older to purchase.